First Hedgehog Pathway Inhibitor Approved in AML Patients

Clinicians now have a new treatment to offer elderly patients with newly diagnosed acute myeloid leukemia who have comorbidities that preclude the use of intensive chemotherapy.

Source: CancerNetwork - December 13, 2018 Category: Cancer & Oncology Authors: John Schieszer Source Type: news